MedTrace Logo

Clinical Effects of Gelified Ethanol Application in Cervical Disc Hernia

NCT02834676 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2016-07-15

No results posted yet for this study

Summary

The aim of the study is to evaluate the clinical effects of Discogel® Radiopaque Gelified Ethanol as therapeutic substance for nucleolysis application in the patients with cervical disc hernia who had chronic pain and weakness on the neck, shoulders and arms.

Conditions

Interventions

DRUG

Gelified Ethanol

Pain relief with chemonucleolysis by using gelified ethanol regard to age, sex, ASA score, and complications.

Sponsors & Collaborators

  • Sakarya University

    lead OTHER

Principal Investigators

  • Serbülent G Beyaz, AssocProf · Clinical Chair

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-05-31
Completion
2017-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02834676 on ClinicalTrials.gov